Follow the ISMA on Twitter
The ISMA has developed a Twitter page to deliver updates about medical matters and events that are important to you.
Twitter is a free online social networking tool that helps people stay connected through brief text messages up to 140 characters in length. It is a useful resource to release important information quickly.
You can follow us at www.twitter.com/theisma using a Web browser or sign-up for a Twitter account and receive posts by phone or computer. Visit www.twitter.com to sign-up.
Comment on ISMA Reports articles
If you’ve ever read an ISMA Reports article and wanted to share your opinion about it or see what your colleagues are thinking, now you can.
To make or view comments, go to the ISMA News section from the Web site menu, choose the article you would like to comment on and click the comment link at the bottom of the page. After clicking the link, the site will prompt you to login.
You may also go directly to the article you want by clicking on the appropriate link in the ISMA Reports e-mail version, e-Reports.
If you need assistance with your ISMA Web site login, please contact the ISMA at (317) 261-2060 or (800) 257-4762.
You must have a login to use the comment section. If you’re not receiving e-Reports, send an e-mail to Vicki Riley to be added to the distribution list.
“Share” button on articles
In addition to commenting on ISMA Reports articles, you can now send them easily to others by using the “share” button located in the top right corner of the online article, just next to the headline.
You can e-mail, print or post the article with numerous social networking Web sites by selecting the appropriate service from the menu.
See what the ISMA is up to on Facebook
See pictures and videos from ISMA events, get up to date news and information or just see what the ISMA is working on. Visit Facebook.com/theISMA.
Show your professional involvement by linking up on LinkedIn
On LinkedIn? Join the ISMA group and link us to your network. Add your point of view to our professional discussions or start one of your own at www.ismanet.org/go/LinkedIn.